C

Curaleaf Holdings Inc
CNSX:CURA

Watchlist Manager
Curaleaf Holdings Inc
CNSX:CURA
Watchlist
Price: 6.59 CAD 0.15%
Market Cap: 4.8B CAD
Have any thoughts about
Curaleaf Holdings Inc?
Write Note

Curaleaf Holdings Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Curaleaf Holdings Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
C
Curaleaf Holdings Inc
CNSX:CURA
Accrued Liabilities
$118m
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Accrued Liabilities
$3.3B
CAGR 3-Years
-12%
CAGR 5-Years
2%
CAGR 10-Years
5%
Canopy Growth Corp
TSX:WEED
Accrued Liabilities
CA$42.7m
CAGR 3-Years
-21%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
Accrued Liabilities
CA$46.2m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Accrued Liabilities
$32.7m
CAGR 3-Years
123%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Accrued Liabilities
$8.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Curaleaf Holdings Inc
Glance View

Market Cap
4.8B CAD
Industry
Pharmaceuticals

Curaleaf Holdings Inc. is a prominent player in the burgeoning cannabis industry. With its roots firmly planted in Massachusetts, Curaleaf quietly grew from a regional entity into a nationwide powerhouse. The company's business model intricately intertwines cultivation, processing, and retail. Curaleaf's vertically integrated structure allows for end-to-end control of its product lifecycle, enhancing both quality assurance and profit margins. They meticulously nurture cannabis plants from seed to harvest, which are then transformed into a range of products, spanning from flower and oil concentrates to edibles and topicals. This comprehensive approach not only supports supply chain efficiency but also significantly bolsters brand consistency and customer satisfaction. Curaleaf's revenue streams flow primarily from its retail operations, where they operate an extensive chain of dispensaries across multiple states. Their strategic acquisitions and mergers have only expanded their footprint, allowing them to tap into diverse markets with varying regulatory landscapes. By establishing a strong retail presence, Curaleaf deftly navigates the complex regulatory frameworks governing cannabis sales, enhancing their market reach and consumer base. Additionally, the company has been proactive in pursuing partnerships and brand extensions, further diversifying its offerings and appealing to a broader audience. This multi-faceted strategy enables Curaleaf to capture a significant share of the growing demand for cannabis-related products, setting a robust foundation for sustained financial growth in an industry poised for expansion.

CURA Intrinsic Value
3.7 CAD
Overvaluation 44%
Intrinsic Value
Price
C

See Also

What is Curaleaf Holdings Inc's Accrued Liabilities?
Accrued Liabilities
118m USD

Based on the financial report for Sep 30, 2023, Curaleaf Holdings Inc's Accrued Liabilities amounts to 118m USD.

What is Curaleaf Holdings Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
38%

Over the last year, the Accrued Liabilities growth was 24%. The average annual Accrued Liabilities growth rates for Curaleaf Holdings Inc have been 38% over the past three years .

Back to Top